Literature DB >> 10071196

Refined genetic and physical positioning of the gene for Doyne honeycomb retinal dystrophy (DHRD).

S Kermani1, K Gregory-Evans, E E Tarttelin, J Bellingham, C Plant, A C Bird, M Fox, S S Bhattacharya, C Y Gregory-Evans.   

Abstract

Doyne honeycomb retinal dystrophy (DHRD) is a late-onset autosomal dominant disorder that causes degeneration of the retina and can lead to blindness. We have previously assigned DHRD to a 5-cM region of chromosome 2p16 between marker loci D2S2739 and D2S378. Using sequence-tagged sites (STSs), expressed sequence tags (ESTs) and polymorphic markers within the DHRD region, we have identified 18 yeast artificial chromosomes (YACs) encompassing the DHRD locus, spanning approximately 3 Mb. The YAC contig was constructed by STS content mapping of these YACs and incorporates 13 STSs, including four genes and six polymorphic marker loci. We also report the genetic mapping of two families with a dominant drusen phenotype to the DHRD locus, and genetic refinement of the disease locus to a critical interval flanked by microsatellite marker loci D2S2352 and D2S2251, a distance of approximately 700 kb. These studies exclude a number of candidate genes and provide a resource for construction of a transcriptional map of the region, as a prerequisite to identification of the DHRD disease-causing gene and genes for other diseases mapping in the region, such as Malattia leventinese and Carney complex.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10071196     DOI: 10.1007/s004390050913

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  5 in total

1.  Molecular genetic heterogeneity in autosomal dominant drusen.

Authors:  E E Tarttelin; C Y Gregory-Evans; A C Bird; R G Weleber; M L Klein; J Blackburn; K Gregory-Evans
Journal:  J Med Genet       Date:  2001-06       Impact factor: 6.318

2.  A novel haplotype with the R345W mutation in the EFEMP1 gene associated with autosomal dominant drusen in a Japanese family.

Authors:  Tomokazu Takeuchi; Takaaki Hayashi; Matthew Bedell; Kang Zhang; Hisashi Yamada; Hiroshi Tsuneoka
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-22       Impact factor: 4.799

Review 3.  CRISPR/Cas9 genome surgery for retinal diseases.

Authors:  Christine L Xu; Karen Sophia Park; Stephen H Tsang
Journal:  Drug Discov Today Technol       Date:  2018-06-18

4.  A novel isoform of beta-spectrin II localizes to cerebellar Purkinje-cell bodies and interacts with neurofibromatosis type 2 gene product schwannomin.

Authors:  Y Chen; P Yu; D Lu; D A Tagle; T Cai
Journal:  J Mol Neurosci       Date:  2001-08       Impact factor: 2.866

Review 5.  Proline metabolism and transport in retinal health and disease.

Authors:  Jianhai Du; Siyan Zhu; Rayne R Lim; Jennifer R Chao
Journal:  Amino Acids       Date:  2021-04-19       Impact factor: 3.520

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.